2型糖尿病短期胰岛素强化治疗临床专家指导意见

被引：80

作者：

李延兵 ^{[1
]}

马建华 ^{[2
]}

母义明 ^{[3
]}

机构：

[1] 中山大学附属第一医院内分泌科

[2] 南京市第一医院内分泌科

[3] 解放军总医院内分泌科

来源：

药品评价 | 2017年 / 14卷 / 09期

关键词：

胰岛素强化治疗; 糖尿病,2型; 指导意见;

D O I：

暂无

中图分类号：

R587.1 [糖尿病];

学科分类号：

100201 [内科学];

摘要：

胰岛素强化治疗是强化血糖控制的重要方法之一。临床上,伴有明显的高血糖症状的新诊断2型糖尿病（type 2 diabetes,T2DM）患者,或者已诊断为T2DM、使用两种或两种以上口服降糖药联合治疗3个月以上血糖仍明显升高[糖化血红蛋白(hemoglobin A-（1c）,Hb A1c)>9.0%],以及已经起始胰岛素治疗且经过充分的剂量调整血糖仍未达标(Hb A1c>7.0%)的T2DM患者,往往需要进行短期的胰岛素强化治疗以短时间内改善高糖毒性。然而,对短期胰岛素强化治疗的具体指征、治疗方案的选择、胰岛素剂量调整方法,以及强化治疗之后的后续治疗方案如何选择等仍缺乏具体指导。因此,中国内分泌学专家基于现有的证据和临床经验,制订了《2型糖尿病短期胰岛素强化治疗临床专家指导意见》。

引用

页码：5 / 12+26 +26

页数：9

共 18 条

[1]

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial [J].

Aronson, R. ;

Reznik, Y. ;

Conget, I. ;

Castaneda, J. A. ;

Runzis, S. ;

Lee, S. W. ;

Cohen, O. .

DIABETES OBESITY & METABOLISM, 2016, 18 (05) :500-507

[2]

Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission [J].

Liu, Liehua ;

Ke, Weijian ;

Wan, Xuesi ;

Zhang, Pengyuan ;

Cao, Xiaopei ;

Deng, Wanping ;

Li, Yanbing .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (02) :250-257

[3]

Clinical predictors and time course of the improvement in β–cell function with short‐term intensive insulin therapy in patients with Type 2 diabetes.[J].C. M. Stein;C. K. Kramer;B. Zinman;H. Choi;C. Opsteen;R. Retnakaran.Diabet. Med..2015, 5

[4]

Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial [J].

Jia, Weiping ;

Xiao, Xinhua ;

Ji, Qiuhe ;

Ahn, Kyu-Jeung ;

Chuang, Lee-Ming ;

Bao, Yuqian ;

Pang, Can ;

Chen, Lei ;

Gao, Fei ;

Tu, Yinfang ;

Li, Pengfei ;

Yang, Jun .

LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04) :254-262

[5]

Efficacy of metformin‐based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short‐term intensive insulin therapy<link href="#jdb12167-note-0010"/>.[J].Qingfeng Cheng;Shumin Yang;Changhong Zhao;Zhihong Wang;Zhengping Feng;Rong Li;Peng Ye;Suhua Zhang;Huacong Deng;Bo Zhou;Jian Long;Lilin Gong;Hua Qing;Cheng Luo;Qifu Li.Journal of Diabetes.2015, 2

[6]

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial [J].